← Back to Search
The Hill Equation: A Review Of Its Capabilities In Pharmacological Modelling
S. Goutelle, M. Maurin, F. Rougier, X. Barbaut, L. Bourguignon, M. Ducher, P. Maire
Published 2008 · Mathematics, Medicine
Download PDFAnalyze on Scholarcy
The Hill equation was first introduced by A.V. Hill to describe the equilibrium relationship between oxygen tension and the saturation of haemoglobin. In pharmacology, the Hill equation has been extensively used to analyse quantitative drug–receptor relationships. Many pharmacokinetic–pharmacodynamic models have used the Hill equation to describe nonlinear drug dose–response relationships. Although the Hill equation is widely used, its many properties are not all well known. This article aims at reviewing the various properties of the Hill equation. The descriptive aspects of the Hill equation, in particular mathematical and graphical properties, are examined, and related to Hill’s original work. The mechanistic aspect of the Hill equation, involving a strong connection with the Guldberg and Waage law of mass action, is also described. Finally, a probabilistic view of the Hill equation is examined. Here, we provide some new calculation results, such as Fisher information and Shannon entropy, and we introduce multivariate probabilistic Hill equations. The main features and potential applications of this probabilistic approach are also discussed. Thus, within the same formalism, the Hill equation has many different properties which can be of great interest for those interested in mathematical modelling in pharmacology and biosciences.
This paper references
Pharmacokinetic–Pharmacodynamic Modelling: History and Perspectives
C. Csajka (2005)
J. H. Gaddum (1948)
In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats.
R. A. Giuliano (1986)
The Hill equation in pharmacological modelling dynamics of piperacillin in neutropenic mice of systematic infection due to Pseudomonas aeruginosa
Response Surface Model for Anesthetic Drug Interactions
C. Minto (2000)
The quantitative analysis of drug-receptor interactions: a short history.
D. Colquhoun (2006)
PK-PD curve-fitting problems with the Hill equation? Try one of the 1-exp functions derived from Hodgkin, Douglas or Gompertz.
F. Keller (2002)
Pharmacodynamie clinique des antibiotiques Précis de Bactériologie Clinique, Section XI, Chapitre 16, 2e e ´dition
L Bourguignon (2007)
Affinity and intrinsic activity in the theory of competitive inhibition. I. Problems and theory.
E. J. Ariens (1954)
The Mode of Action of Drugs on Cells
A. B. (1933)
The constitution and fundamental properties of solids and liquids. Part II.—Liquids
I. Langmuir (1917)
Evaluation of therapeutic strategies: a new method for balancing risk and benefit.
C. Troche (2000)
Diversity of mechanism-based pharmacodynamic models.
D. Mager (2003)
Dosage regimens of antibacterials : implications of a pharmacokinetic / pharmacodynamic model
Y. Bouvierd’YvoireM.J. (1996)
THE METHOD OF PROBITS.
C. Bliss (1934)
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
T. Chou (2006)
Cumulative Frequency Functions
I. W. Burr (1942)
Pharmacokinetic and pharmacodynamic modeling in vivo Understanding the dose–effect relationship: clinical application of pharmacokinetic-pharmacodynamic models
N H Holford (1981)
Pharmacokinetic/pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics: the minimum inhibitory concentration vs. stationary concentration
J W Mouton (2005)
Activation of single ion channels from toad retinal rod inner segments by cyclic GMP: concentration dependence.
G. Matthews (1988)
Adaptive control of therapeutic drug regimens relations between clinical situations: outcomes and simulations using nonlinear dynamic models.
P. Maire (1995)
Generalized Linear Models
E. Ziegel (2002)
THE RELATION OF DOSAGE TO EFFECT
L. F. Shackell (1924)
Pharmacodynamic dose adjustment in renal failure: importance of the Hill coefficient.
D. Czock (2006)
Understanding the dose – effect relationship : clinical application of pharmacokinetic - pharmacodynamic models
H. HolfordN. (1981)
Dose Finding Designs for Continuous Responses and Binary Utility
V. Fedorov (2007)
Adaptive Designs for Dose-Finding Studies Based on Sigmoid E max Model
V. Dragalin (2007)
APPLICATION OF THE LAW OF CHEMICAL EQUILIBRIUM (LAW OF MASS ACTION) TO BIOLOGICAL PROBLEMS
F. Mclean (1938)
The Hill equation revisited: uses and misuses
J. Weiss (1997)
A new nonlinear mixture response surface paradigm for the study of synergism: a three drug example.
D. White (2003)
Actes des XXXIVèmes Journées de Statistiques
M Maurin (2002)
Single cyclic GMP-activated channel activity in excised patches of rod outer segment membrane
L. W. Haynes (1986)
Notes de calculs sur les lois de Hill: Aspects probabiliste, déterministe et e ´pistémologique
M Maurin (2000)
Die kinetic der Invertinwirkung
L Michaelis (1913)
The Rate of Action of Drugs on Cells
A. J. Clark (1937)
Mechanism-based pharmacokinetic–pharmacodynamic modeling of antimicrobial drug effects
D. Czock (2007)
Pharmacokinetic / pharmacodynamic modelling of antibacterials in vitro and in vivo using bacterial growth and kill kinetics : the minimum inhibitory concentration vs . stationary concentration
W. MoutonJ. (2005)
Pharmacocinétique / pharmacodynamie clinique des antibiotiques
P. Maire (2000)
Aminoglycoside Nephrotoxicity: Modeling, Simulation, and Control
F. Rougier (2003)
Is dynamical systems modeling just curve fitting?
D. Rosenbaum (1998)
Méthode d'analyse des observations par «tout ou rien»
E. Morice (1959)
Sensitivity analysis of discrete stochastic systems.
R. Gunawan (2005)
Application of a new approach for the quantitation of drug synergism to the combination of cis-diamminedichloroplatinum and 1-beta-D-arabinofuranosylcytosine.
W. Greco (1990)
Hill coefficient for estimating the magnitude of cooperativity in gating transitions of voltage-dependent ion channels.
O. Yifrach (2004)
Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics
J. Mouton (2005)
Using animal data to improve prediction of human decompression risk following air-saturation dives.
R. S. Lillo (2002)
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors.
T. Chou (1984)
Aminoglycoside dosages and nephrotoxicity: quantitative relationships
F Rougier (2003)
Kinetics of pharmacologic response. I. Proposed relationships between response and drug concentration in the intact animal and man.
J. Wagner (1968)
The reaction between acetyl choline and muscle cells
A. J. Clark (1926)
The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves
A. Hill (1910)
Microbial pharmacodynamics of piperacillin in neutropenic mice of systematic infection due toPseudomonas aeruginosa
J. Zhi (2005)
Pharmacokinetic and pharmacodynamic modeling in vivo.
N. Holford (1981)
Goodman and Gilman's The Pharmacological Basis of Therapeutics
Roger L. Black (1981)
Cyclic GMP-sensitive conductance of retinal rods consists of aqueous pores
A. Zimmerman (1986)
Comparison of four basic models of indirect pharmacodynamic responses
Natalie L. Dayneka (2005)
The search for synergy: a critical review from a response surface perspective.
W. Greco (1995)
Modeling of the time-dependency of in vitro drug cytotoxicity and resistance.
L. Levasseur (1998)
Dosage Regimens of Antibacterials
M. Bouvier d'Yvoire (1996)
Derivation and properties of Michaelis-Menten type and Hill type equations for reference ligands.
T. Chou (1976)
Understanding the Dose-Effect Relationship
N. Holford (1981)
A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions.
J. Zhi (1986)
Comparisons between Antimicrobial Pharmacodynamic Indices and Bacterial Killing as Described by Using the Zhi Model
S. Corvaisier (1998)
Dosage regimens of antibacterials: implications of a pharmacokinetic/pharmacodynamic model
M J Y Bouvier D 'yvoire (1996)
This paper is referenced by
The relationship between offspring size and fitness: integrating theory and empiricism.
N. Rollinson (2013)
Increasing extracellular protein concentration reduces intracellular antiretroviral drug concentration and antiviral effect.
L. B. Avery (2013)
Snap-shot multispectral imaging of vascular dynamics in a mouse window-chamber model.
Hansford C. Hendargo (2015)
A bottom-up characterization of transfer functions for synthetic biology designs: lessons from enzymology
M. Carbonell-Ballestero (2014)
Layered material platform for surface plasmon resonance biosensing
F. Wu (2019)
Self-assembly of microcapsules regulated via the repressilator signaling network.
H. Shum (2015)
Detecting gold biomineralization by Delftia acidovorans biofilms on a quartz crystal microbalance.
R. Funari (2019)
Analytical Pumping Speed Models for Electric Propulsion Vacuum Facilities
R. Spektor (2018)
Computational Modeling of Microabscess Formation
A. B. Pigozzo (2012)
Selective complexation of divalent cations by a cyclic α,β-peptoid hexamer: a spectroscopic and computational study.
E. de Santis (2016)
Dynamical Systems Approach to Endothelial Heterogeneity
E. Regan (2012)
Materials challenges of two-dimensional materials for flexible sensing applications
Meng-Yen Tsai (2017)
Subcellular drug targeting, pharmacokinetics and bioavailability
S. Leucuţa (2014)
ill coefficient-based stochastic switch-like signal directly governs amage-recovery dynamics in freshwater fish in response to pulse opper
ei-Yu Chena (2016)
Quantitative Validation of a Yellow Fever Vaccine Model
Carla R. B. Bonin (2019)
Comparative Study of Mathematical Models for Ghana’s Gold Production
S. T. Appiah (2018)
Theory of synergistic effects: Hill-type response surfaces as ‘null-interaction’ models for mixtures
M. Schindler (2017)
High-throughput screen, using time-resolved FRET, yields actin-binding compounds that modulate actin–myosin structure and function
P. Guhathakurta (2018)
Ethanol stimulates the in vivo axonal movement of neuropeptide dense‐core vesicles in Drosophila motor neurons
Gary J Iacobucci (2018)
Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review
V. Ziesenitz (2017)
6-Carboxyfluorescein and structurally similar molecules inhibit DNA binding and repair by O⁶-alkylguanine DNA alkyltransferase.
M. Melikishvili (2011)
Efficacy and tolerability exposure-response relationship of retigabine (ezogabine) immediate-release tablets in patients with partial-onset seizures.
D. Tompson (2013)
Scanning electrochemical microscopy for the investigation of redox potential of human myocardium-derived mesenchymal stem cells grown at 2D and 3D conditions
J. Petronienė (2020)
A Statistical Thermodynamic Model for Ligands Interacting With Ion Channels: Theoretical Model and Experimental Validation of the KCNQ2 Channel
Fang Bai (2018)
Pharmacokinetics and pharmacodynamics of antimicrobial drugs
D. Czock (2009)
Technical Appendix to : A novel model-based meta-analysis to indirectly estimate the comparative efficacy of two medications : an example using DPP-4 inhibitors , sitagliptin and linagliptin , in treatment of type 2 diabetes mellitus December
J. L. Gross (2012)
Genetic, Biochemical, and Functional Characterization of Heme Metabolism in Group A Streptococcus
Ankita J Sachla (2015)
An overview of pharmacodynamic modelling, ligand-binding approach and its application in clinical practice
M. Salahudeen (2017)
Dose-Finding Methodology for Peripheral Nerve Blocks
T. Saranteas (2014)
How many enzyme molecules are needed for discrimination oriented applications?
J. Gorecki (2016)
An analytical approach to bistable biological circuit discrimination using real algebraic geometry
Dan Siegal-Gaskins (2015)
Discrimination of time-dependent inflow properties with a cooperative dynamical system.
H. Ueno (2015)See more